Preclinical results of an ACE2-interacting domain of SARS-CoV-2 peptide for COVID-19 treatment Feb. 16, 2021
Phase II study evaluates E-52862 in early treatment of outpatients with mild COVID-19 symptoms Feb. 15, 2021
Tocilizumab in addition to steroids shows benefit in patients hospitalized with COVID-19 Feb. 15, 2021
A humanized mouse model of Pneumocystis pneumonia to better understand the human immune response Feb. 15, 2021
RSS